INTELLIA THERAPEUTICS, INC. (NTLA) Gross margin 2018–2021
INTELLIA THERAPEUTICS, INC. (NTLA) gross margin by fiscal year — reported gross profit divided by reported revenue.
100.0%FY2021 · since FY2018: 100.0% → 100.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | 100.0% | +0.0 pp |
| FY2020 | 100.0% | +0.0 pp |
| FY2019 | 100.0% | +0.0 pp |
| FY2018 | 100.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More NTLA financial trends
NTLA RevenueNTLA Net incomeNTLA Net marginNTLA Gross profitNTLA Operating incomeNTLA Operating marginNTLA Operating cash flowNTLA Free cash flowNTLA Capital expendituresNTLA Return on equityNTLA Stock buybacksNTLA Dividends paidNTLA Total assetsNTLA Total liabilitiesNTLA Shareholders’ equityNTLA overview →